Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Preclinical activity and pharmacokinetic data presented for UR-9825

Nov. 7, 1997

SPA-S-843 compared in experimental infection models to current antifungals

Nov. 7, 1997

Nyotran compared to other antifungals in vitro

Nov. 7, 1997

U.S. approval for Raxar

Nov. 7, 1997

Roussel Uclaf reports new erythromycin antibiotics

Nov. 7, 1997

New azole antifungals from Zambon/Isagro

Nov. 7, 1997

Potent new fluoroquinolones described by Bayer

Nov. 5, 1997

Oral prodrugs of novel carbapenems prepared at Wyeth-Ayerst

Nov. 4, 1997

U.K. launch for Malarone, a potent new antimalarial combination

Nov. 3, 1997

Oxazolidinone antibacterial agents prepared at P&U

Nov. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...